FDA Drug Recalls

Recalls / Brands / Paclitaxel

Paclitaxel

2 FDA drug recalls involving brand “Paclitaxel”.

DateClassProductFirm
2013-11-08Class IIIPACLITAXEL INJECTION, USP (semisynthetic); 300 mg/50 mL; (6 mg/mL); Multiple Dose Vial;(NDC 63323-763-50); RxFresenius Kabi USA, LLC
2012-06-27Class IIPaclitaxel Injection, 6 mg/mL, 50 mL Single Dose Vial, Rx only, antineoplastic/cytotoxic agent; Manufactured fHospira Inc.